K
4896.TK Pharma,Inc. Price (4896.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
11,604,600
(24.3702)%Cash Flow Statement
K Pharma,Inc.Currency: JPY
| YEAR | 2021 | 2022 | 2023 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -229,119,000.00
+0% |
-390,526,000.00
+70% |
301.08M
-177% |
||||||||||||||||
| Depreciation And Amortiz... | 6.80M | 0.00 | 0.00 | ||||||||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Accounts Payables | -119,000.00 | 7.47M | 1.75M | ||||||||||||||||
| Inventory | -18,000.00 | -313,000.00 | -598,000.00 | ||||||||||||||||
| Other Working Capital | 16.60M | -16,248,000.00 | 89.14M | ||||||||||||||||
| Other Non-Cash Items | 1.40M | 5.51M | 63.06M | ||||||||||||||||
| Net Cash Provided By Op... | -196,320,000.00
+0% |
-363,482,000.00
+85% |
454.43M
-225% |
||||||||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | 0.00 | -29,958,000.00 | -9,803,000.00 | ||||||||||||||||
| Acquisitions Net | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Investing Activities | -250,000.00 | -2,779,000.00 | -1,296,000.00 | ||||||||||||||||
| Net Cash Used For Inv... | -250,000.00
+0% |
-32,737,000.00
+12,995% |
-11,099,000.00
-66% |
||||||||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | -30,000,000.00 | 0.00 | 0.00 | ||||||||||||||||
| Common Stock Issued | 398.20M | 1.54B | 1.50B | ||||||||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Financing Activities | 0.00 | -90,000.00 | -10,090,000.00 | ||||||||||||||||
| Net Cash Used/Provide... | 368.20M
+0% |
1.54B
+319% |
1.49B
-4% |
||||||||||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Net Change In Cash | 171.63M | 1.15B | 1.93B | ||||||||||||||||
| Cash At Beginning Of Per... | 17.15M | 188.78M | 1.34B | ||||||||||||||||
| Cash At End Of Period | 188.78M | 1.34B | 3.27B | ||||||||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | -196,320,000.00 | -363,482,000.00 | 454.43M | ||||||||||||||||
| Capital Expenditure | 0.00 | -29,958,000.00 | -9,803,000.00 | ||||||||||||||||
| Free Cash Flow | -196,320,000.00
+0% |
-393,440,000.00
+100% |
444.62M
-213% |
||||||||||||||||